The Formation of Cytidine Nucleotides and RNA Cytosine from Orotic Acid by the Novikoff Tumor in Vitro*

Total Page:16

File Type:pdf, Size:1020Kb

The Formation of Cytidine Nucleotides and RNA Cytosine from Orotic Acid by the Novikoff Tumor in Vitro* The Formation of Cytidine Nucleotides and RNA Cytosine from Orotic Acid by the Novikoff Tumor in Vitro* HAROLD O. KAMMEN t AND ROBERT B. HURLBERT (Biochemistry Department, The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston f~5, Tezas) The utilization of orotic acid for the formation the amino group of cytosine compounds in ma- of RNA ~uracil has been extensively studied in in- malian tissues may be derived from glutamine, in- tact animals, tissue slices, and cell suspensions (re- stead of ammonia. Eidinoff et al. (9) have shown viewed in Refs. 5, 31). The mechanism of the the glutamine antagonist, DON, to depress sig- utilization, via the initial conversion of orotic acid nificantly the incorporation of orotic acid into the to uridine nucleotides and the incorporation of uri- nucleic acid cytosine of rat tissues, both in vivo dine nucleotides into polynucleotides, has been and in tissue slices. Salzman et al. (33) have found partially described in intact animals (13, 17) and the amide group of glutamine to be the source of studied in detail in enzyme systems of microbial, the amino group of the polynucleotide cytosine avian, and mammalian origin (18, 36) (reviewed in HeLa cell cultures. In a preliminary report (31) in Refs. 33, 38, 39). The concomitant conversion we have described a soluble enzyme system, of orotic acid to RNA cytosine has usually been present in both the Novikoff rat tumor and rat observed in intact cell systems, in vivo and in liver, capable of the conversion of orotic acid to vitro, but is smaller, more variable, and apparent- uridine nucleotides and of the amination of the ly of secondary nature as compared with the con- uridine nucleotides to cytidine nucleotides. ATP version to RNA uracil (1, 7, 13, 14, 16, 18, 33, 34). and glutamine were required for the amination Lieberman (35) has demonstrated the direct step, guanosine nucleotides appeared to serve as amination of uridine triphosphate to form cytidine cofactors, and DON was inhibitory. triphosphate; the enzyme system, purified from In the work reported here, the objective was to Escherichia coli, required ammonia and ATP. The establish whether the enzymatic steps observed in existence of this reaction suggests strongly that the soluble system were part of the normal path- the uridine nucleotides and cytidine nucleotides way for the conversion of orotic acid to RNA cyto- are involved as intermediates in the conversion of sine in surviving Novikoff tumor tissue. The ef- orotic acid to RNA cytosine. fects of glutamine, other amino donors, glutamine Evidence has more recently been offered that antagonists, and uridine were examined in intact * Aided by grants from the American Cancer Society cell preparations of the tumor incubated with (P-146) and from the Anna Fuller Fund. With the assistance orotic acid-6-C TM. The labeling of the cytidine of Joyce Danielson Miller, Alice F. Wheeler, and Audrey F. nucleotides and RNA cytosine was compared with Posey. This work forms part of the dissertation submitted by the labeling of the uridine nucleotides and RNA Harold O. Kammen to the Department of Chemistry and uracil. To provide further perspective, the inter- Chemical Engineering, Stanford University, for the degree of Doctor of Philosophy, 1959. relationships among all the major "acid-soluble" pyrimidine metabolites of orotic acid were also I" Present address: Department of Pharmacology, Yale University, New Haven, Connecticut. examined. These metabolites (cytidine nucleo- ' The abbreviations used are: RNA (ribonucleieacid), DNA tides, cytidine, cytosine, uridine nucleotides, uri- (deoxyribonucleic acid), ATP (adenosine-5'-triphosphate), dine, and uracil) were separated from cold per- UMP (uridine-5'-phosphate), CMP (cytidine-5'-phosphate), chloric acid extracts of the tissue by ion-exchange DON (6-diazo-5-oxo-L-norleucine), and azaserine (0-diazo- and paper chromatographic methods. A brief re- acetyl-~serine). "Uridylic acid" and "cytidylic acid" represent the mixed $'- and 3'-monophosphates of uridine and cytidine, port has appeared (30). respectively, derived by alkaline hydrolysis of RNA. "Uridine nucleotides" and "cytidine nucleotides" represent the groups MATERIALS AND METHODS of nucleoside-5'-phosphate and -5'-pyrophosphate monomeric Materials.--The orotic acid-6-C 14 was pur- compounds extractable by cold percMoric acid and hydrolyz- chased from Tracerlab, Inc., the uniformly C 14- able to UMP and CMP, respectively. labeled cytidine from Schwarz Laboratories, Inc., Received for publication February 9, 1959. and the amino acids (L-isomers)from the Cali- 654 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 1959 American Association for Cancer Research. KAMMEN AND HURLBERT--Formation of RNA Cytosine 655 fornia Corporation for Biochemical Research. The in a 13-ml. tube, and the precipitated tissue was re- azaserine bore the Parke, Davis and Company lot extracted with 0.4 N perchloric acid; the combined number 2342 X 35, and the DON s bore the Sloan- extracts (7-8 ml. total volume) constituted the Kettering Institute number SK 13,835 ab. The "cold perchloric acid extract." The precipitate was azaserine and DON materials were checked by further washed with two 8-ml. portions of cold published spectrophotometric criteria and found 0.4 ~r perchlorie acid, and 3 ml. of cold 12 per cent to be 59 per cent azaserine (3) and 87 per cent NaC1 was added. The suspension was neutralized DON (8), respectively. Other chemicals were com- carefully with a minimum volume of NaOH solu- mercial products of reagent quality. tion (phenol red indicator) and heated at 100~ C. The Novikoff transplantable hepatoma s (27) for 30 minutes to extract the sodium nucleate (12, was carried in 350-500-gm. female Holtzmann 16). The precipitate was centrifuged and re- Sprague-Dawley rats and was transplanted every extracted for a few minutes with 1 mi. of hot 10 5th day by the intraperitoneal injection of 100- per cent NaC1. The combined salt extracts were 300 mg. of fresh, minced tissue suspended in treated with 2.5 volumes of ethanol at - 10~ C. for 0.15 M NaC1. The tumor for the experimental work several hours to precipitate the sodium nucleate, was taken on the 5th day, when the rats were which was then washed twice with 5-ml. portions usually severely hemorrhagic. The large mass of of cold 80 per cent ethanol and dissolved in 2.0 ml. tumor in the greater omentum and a smaller mass of water. The sodium nucleate solution was brought adjacent to the spleen were removed, chilled, to 0.3 s NaOH and incubated overnight at 88 ~ C. cleaned of the larger blood clots, passed through The DNA was precipitated by the addition of 1 a stainless steel mesh in a large syringe, and sus- volume of 0.4 N perchloric acid (cold); the acid pended in the Krebs-Ringer phosphate-glucose solution and a 1-ml. wash with 0.1 N perchloric (KRPG) medium (see below). The free blood cells acid constituted the "RNA" fraction. The DNA were removed by suspending and sedimenting the was dissolved in 2 ml. of 0.1 s NaOH, the solution tumor tissue 2 or 3 times in the KRPG medium, was heated at 80 ~ C. for 5 minutes (I3), neutral- with centrifugation at about 100 X g for 1-2 ized, and treated with 2.5 volumes of cold ethanol. minutes at 2 ~ C. The packed tissue was diluted The precipitated sodium deoxyribonucleate was with the KRPG solution to a 30 per cent suspen, washed twice with 5-ml. portions of 80 per cent sion (v/v). The composition of the modified ethanol and dissolved in 3.0 pal. of water for KRPG solution was: 0.125 M NaCl, 0.015 M KCI, analysis. 0.003 ~ CaCb, 0.00067 M MgCl2, 0.006 M sodium Analysis and chromatography.--The RNA and DNA con- phosphate, pH 7.4, and 0.030 M D-glucose. In some tent of the sodium nucleate solution and DNA content of the cases the tissue was washed and suspended in the sodium deoxyribonucleate solution were determined. In addi- Krebs-Ringer salts solution, with separate addi- tion, the RNA and DNA remaining in the tissue residue after extraction of the nucleates were estimated by analysis of an tion of the phosphate and glucose to the incuba- extract made with hot 0.4 N perchloric acid. All data have been tion flasks. calculated to include and correct for this residual RNA and Incubation and preparation of samples.--Ali- DNA (less than 10 per cent of the total). There was no de- quots of the tissue suspension were pipetted into tectable cross-contamination of the "RNA" and the sodium the incubation flasks; the relative amount of deoxyribonucleate fractious. The analyses for RNA were made by a modified orcinol procedure (19) and for DNA by Burton's tissue in each flask was estimated by analyses for modification of the Dische diphenylamine procedure (6). DNA at the end of the incubation. The incubation (Commercial yeast RNA and sperm DNA were used as mixtures were prepared and kept at 0 ~ in 50-ml. standards.) Erlenmeyer flasks, flushed with 95 per cent Oz-5 Each "RNA" fraction was brought to 1 N perchloric acid by the addition of 11.5 N perchloric acid, heated at 100~ C. for 80 per cent CO~ before !and after the addition of the minutes to destroy the purine nucleotides, and neutralized at tissue. During the incubation the stoppered flasks 0 ~ C. with the minimum volume of concentrated KOH. The were shaken about 100 cycles per minute at 38 ~ C. KC104 precipitate was washed twice by centrifugation with in a water bath. 'The pH of the medium decreased several ml. of cold water; the solution and washes were chro- to nearly 6.8 during the course of the incubations.
Recommended publications
  • A Guardian of the Development of Diabetic Retinopathy
    Diabetes Volume 67, April 2018 745 Sirt1: A Guardian of the Development of Diabetic Retinopathy Manish Mishra, Arul J. Duraisamy, and Renu A. Kowluru Diabetes 2018;67:745–754 | https://doi.org/10.2337/db17-0996 Diabetic retinopathy is a multifactorial disease, and the molecular mechanism of the development of diabetic reti- exact mechanism of its pathogenesis remains obscure. nopathy remains to be established. Sirtuin 1 (Sirt1), a multifunctional deacetylase, is impli- Sirtuin 1 (Sirt1), a member of the silent information cated in the regulation of many cellular functions and in regulator 2 family, is a class III histone deacetylase that gene transcription, and retinal Sirt1 is inhibited in di- interacts with target proteins and regulates many cellular abetes. Our aim was to determine the role of Sirt1 in the functions including cell proliferation, apoptosis, and inflam- development of diabetic retinopathy and to elucidate the matory responses (6–8). Sirt1 is mainly a nuclear protein, Sirt1 molecular mechanism of its downregulation. Using - and its activity depends on cellular NAD availability (9). It is overexpressing mice that were diabetic for 8 months, Sirt1 expressed throughout the retina, and upregulation of COMPLICATIONS structural, functional, and metabolic abnormalities were protects against various ocular diseases including retinal investigated in vascular and neuronal retina. The role of degeneration, cataract, and optic neuritis (10). Our previous epigenetics in Sirt1 transcriptional suppression was inves- work has shown that Sirt1 expression and activity are de- tigated in retinal microvessels. Compared with diabetic wild-type mice, retinal vasculature from diabetic Sirt1 mice creased in the retina and its capillary cells in diabetes (11).
    [Show full text]
  • Role of Citicoline in the Management of Traumatic Brain Injury
    pharmaceuticals Review Role of Citicoline in the Management of Traumatic Brain Injury Julio J. Secades Medical Department, Ferrer, 08029 Barcelona, Spain; [email protected] Abstract: Head injury is among the most devastating types of injury, specifically called Traumatic Brain Injury (TBI). There is a need to diminish the morbidity related with TBI and to improve the outcome of patients suffering TBI. Among the improvements in the treatment of TBI, neuroprotection is one of the upcoming improvements. Citicoline has been used in the management of brain ischemia related disorders, such as TBI. Citicoline has biochemical, pharmacological, and pharmacokinetic characteristics that make it a potentially useful neuroprotective drug for the management of TBI. A short review of these characteristics is included in this paper. Moreover, a narrative review of almost all the published or communicated studies performed with this drug in the management of patients with head injury is included. Based on the results obtained in these clinical studies, it is possible to conclude that citicoline is able to accelerate the recovery of consciousness and to improve the outcome of this kind of patient, with an excellent safety profile. Thus, citicoline could have a potential role in the management of TBI. Keywords: CDP-choline; citicoline; pharmacological neuroprotection; brain ischemia; traumatic brain injury; head injury Citation: Secades, J.J. Role of 1. Introduction Citicoline in the Management of Traumatic brain injury (TBI) is among the most devastating types of injury and can Traumatic Brain Injury. result in a different profile of neurological and cognitive deficits, and even death in the most Pharmaceuticals 2021, 14, 410.
    [Show full text]
  • Cytosine-Rich
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 12116-12121, October 1996 Chemistry Inter-strand C-H 0 hydrogen bonds stabilizing four-stranded intercalated molecules: Stereoelectronic effects of 04' in cytosine-rich DNA (base-ribose stacking/sugar pucker/x-ray crystallography) IMRE BERGERt, MARTIN EGLIt, AND ALEXANDER RICHt tDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and tDepartment of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611-3008 Contributed by Alexander Rich, August 19, 1996 ABSTRACT DNA fragments with stretches of cytosine matic cytosine ring systems from intercalated duplexes (Fig. 1A). residues can fold into four-stranded structures in which two Second, unusually close intermolecular contacts between sugar- parallel duplexes, held together by hemiprotonated phosphate backbones in the narrow grooves are observed, with cytosine-cytosine+ (C C+) base pairs, intercalate into each inter-strand phosphorus-phosphorus distances as close as 5.9 A other with opposite polarity. The structural details of this (5), presumably resulting in unfavorable electrostatic repulsion if intercalated DNA quadruplex have been assessed by solution not shielded by cations or bridging water molecules. NMR and single crystal x-ray diffraction studies of cytosine- The close contacts between pairs of antiparallel sugar- rich sequences, including those present in metazoan telo- phosphate backbones from the two interdigitated duplexes are meres. A conserved feature of these structures is the absence a unique characteristic of four-stranded intercalated DNA. of stabilizing stacking interactions between the aromatic ring Indeed, the unusually strong nuclear overhauser effect signals systems of adjacent C-C+ base pairs from intercalated du- between inter-strand sugar Hi' protons and Hi' and H4' plexes.
    [Show full text]
  • Chapter 23 Nucleic Acids
    7-9/99 Neuman Chapter 23 Chapter 23 Nucleic Acids from Organic Chemistry by Robert C. Neuman, Jr. Professor of Chemistry, emeritus University of California, Riverside [email protected] <http://web.chem.ucsb.edu/~neuman/orgchembyneuman/> Chapter Outline of the Book ************************************************************************************** I. Foundations 1. Organic Molecules and Chemical Bonding 2. Alkanes and Cycloalkanes 3. Haloalkanes, Alcohols, Ethers, and Amines 4. Stereochemistry 5. Organic Spectrometry II. Reactions, Mechanisms, Multiple Bonds 6. Organic Reactions *(Not yet Posted) 7. Reactions of Haloalkanes, Alcohols, and Amines. Nucleophilic Substitution 8. Alkenes and Alkynes 9. Formation of Alkenes and Alkynes. Elimination Reactions 10. Alkenes and Alkynes. Addition Reactions 11. Free Radical Addition and Substitution Reactions III. Conjugation, Electronic Effects, Carbonyl Groups 12. Conjugated and Aromatic Molecules 13. Carbonyl Compounds. Ketones, Aldehydes, and Carboxylic Acids 14. Substituent Effects 15. Carbonyl Compounds. Esters, Amides, and Related Molecules IV. Carbonyl and Pericyclic Reactions and Mechanisms 16. Carbonyl Compounds. Addition and Substitution Reactions 17. Oxidation and Reduction Reactions 18. Reactions of Enolate Ions and Enols 19. Cyclization and Pericyclic Reactions *(Not yet Posted) V. Bioorganic Compounds 20. Carbohydrates 21. Lipids 22. Peptides, Proteins, and α−Amino Acids 23. Nucleic Acids **************************************************************************************
    [Show full text]
  • 2'-Deoxyguanosine Toxicity for B and Mature T Lymphoid Cell Lines Is Mediated by Guanine Ribonucleotide Accumulation
    2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. Y Sidi, B S Mitchell J Clin Invest. 1984;74(5):1640-1648. https://doi.org/10.1172/JCI111580. Research Article Inherited deficiency of the enzyme purine nucleoside phosphorylase (PNP) results in selective and severe T lymphocyte depletion which is mediated by its substrate, 2'-deoxyguanosine. This observation provides a rationale for the use of PNP inhibitors as selective T cell immunosuppressive agents. We have studied the relative effects of the PNP inhibitor 8- aminoguanosine on the metabolism and growth of lymphoid cell lines of T and B cell origin. We have found that 2'- deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels. Growth inhibition and GTP accumulation are prevented by hypoxanthine or adenine, but not by 2'-deoxycytidine.
    [Show full text]
  • Drug-Excipient Interaction and Its Importance in Dosage Form
    Journal of Applied Pharmaceutical Science 01 (06); 2011: 66-71 ISSN: 2231-3354 Drug-excipient interacti on and its importance in Received: 29-07-2011 Revised on: 02-08-2011 Accepted: 04-08-2011 dosage form development Nishath Fathima, Tirunagari Mamatha, Husna Kanwal Qureshi, Nandagopal Anitha and Jangala Venkateswara Rao ABSTRACT Excipients are included in dosage forms to aid manufacture, administration or absorption. Although considered pharmacologically inert, excipients can initiate, propagate or participate in Nishath Fathima, Tirunagari chemical or physical interactions with drug compounds, which may compromise the effectiveness Mamatha, Husna Kanwal Qureshi, of a medication. Exicipients are not exquisitely pure. Even for the most commonly used excipients, Nandagopal Anitha and Jangala it is necessary to understand the context of their manufacture in order to identify potential active pharmaceutical ingredients interactions with trace components. Chemical interactions can lead to Venkateswara Rao Sultan-Ul-Uloom College of Pharmacy, degradation of the active ingredient, thereby reducing the amount available for therapeutic effect. Physical interactions can affect rate of dissolution, uniformity of dose or ease of administration. Banjara Hills, Hyderabad - 500034, A.P., India. Key words: Excipient, Drug, Interaction, Physical, Chemical. INTRODUCTION Pharmaceutical dosage form is a combination of active pharmaceutical ingredients (API) and excipients. Excipients are included in dosage forms to aid manufacture, administration or absorption (Crowley and Martini).The ideal excipients must be able to fulfill the important functions i.e. dose, stability and release of API from the formulation. Although considered pharmacologically inert, excipients can initiate, propagate or participate in chemical or physical interactions with drug compounds, which may compromise the effectiveness of a medication.
    [Show full text]
  • DNA Modifications in Models of Alcohol Use Disorders
    Alcohol 60 (2017) 19e30 Contents lists available at ScienceDirect Alcohol journal homepage: http://www.alcoholjournal.org/ DNA modifications in models of alcohol use disorders * Christopher T. Tulisiak a, R. Adron Harris a, b, Igor Ponomarev a, b, a Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, 2500 Speedway, A4800, Austin, TX 78712, USA b The College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1900, Austin, TX 78712, USA article info abstract Article history: Chronic alcohol use and abuse result in widespread changes to gene expression, some of which Received 2 September 2016 contribute to the development of alcohol-use disorders (AUD). Gene expression is controlled, in part, by a Received in revised form group of regulatory systems often referred to as epigenetic factors, which includes, among other 3 November 2016 mechanisms, chemical marks made on the histone proteins around which genomic DNA is wound to Accepted 5 November 2016 form chromatin, and on nucleotides of the DNA itself. In particular, alcohol has been shown to perturb the epigenetic machinery, leading to changes in gene expression and cellular functions characteristic of Keywords: AUD and, ultimately, to altered behavior. DNA modifications in particular are seeing increasing research Alcohol fi Epigenetics in the context of alcohol use and abuse. To date, studies of DNA modi cations in AUD have primarily fi fi fi DNA methylation looked at global methylation pro les in human brain and blood, gene-speci c methylation pro les in DNMT animal models, methylation changes associated with prenatal ethanol exposure, and the potential DNA hydroxymethylation therapeutic abilities of DNA methyltransferase inhibitors.
    [Show full text]
  • A Single-Label Phenylpyrrolocytidine Provides a Molecular Beacon-Like Response Reporting HIV-1 RT Rnase H Activity Alexander S
    1048–1056 Nucleic Acids Research, 2010, Vol. 38, No. 3 Published online 20 November 2009 doi:10.1093/nar/gkp1022 A single-label phenylpyrrolocytidine provides a molecular beacon-like response reporting HIV-1 RT RNase H activity Alexander S. Wahba1, Abbasali Esmaeili2, Masad J. Damha1 and Robert H. E. Hudson3,* 1Department of Chemistry, McGill University, Montreal, QC, H3A 2K6 Canada, 2Department of Chemistry, University of Birjand, Birjand, Iran and 3Department of Chemistry, University of Western Ontario, London, ON, N6A 5B7 Canada Downloaded from https://academic.oup.com/nar/article/38/3/1048/3112336 by guest on 27 September 2021 Received August 15, 2009; Revised and Accepted October 19, 2009 ABSTRACT identified as a potential target for antiretroviral therapy as it is required for virus infectivity (3); yet there are no 6-Phenylpyrrolocytidine (PhpC), a structurally con- antiRNase H agents in clinical use. Few inhibitors of HIV- servative and highly fluorescent cytidine analog, 1 RNase H were identified until the transition of testing was incorporated into oligoribonucleotides. The methods from gel-based techniques to fluorescent assays PhpC-containing RNA formed native-like duplex amenable to high-throughput screening (HTS) (4–8). The structures with complementary DNA or RNA. The most widely used assay was developed by Parniak and co- PhpC-modification was found to act as a sensitive workers (6) and utilizes a two label, molecular beacon reporter group being non-disruptive to structure and strategy (9) in which the RNA strand is labeled with a 0 the enzymatic activity of RNase H. A RNA/DNA 3 -terminal fluorophore (fluorescein, F) and a DNA 0 hybrid possessing a single PhpC insert was an strand with a quencher (dabcyl, Q) at the 5 -terminus excellent substrate for HIV-1 RT Ribonuclease H (Scheme 1).
    [Show full text]
  • High-Throughput Profiling of Nucleotides and Nucleotide Sugars
    Journal of Biotechnology 229 (2016) 3–12 Contents lists available at ScienceDirect Journal of Biotechnology j ournal homepage: www.elsevier.com/locate/jbiotec High-throughput profiling of nucleotides and nucleotide sugars to evaluate their impact on antibody N-glycosylation a,1 b,1 a c Thomas K. Villiger , Robert F. Steinhoff , Marija Ivarsson , Thomas Solacroup , c c b b b Matthieu Stettler , Hervé Broly , Jasmin Krismer , Martin Pabst , Renato Zenobi , a a,d,∗ Massimo Morbidelli , Miroslav Soos a Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, CH- 8093 Zurich, Switzerland b Laboratory of Organic Chemistry, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland c Merck Serono SA, Corsier-sur-Vevey, Biotech Process Sciences, ZI B, CH-1809 Fenil-sur-Corsier, Switzerland d Department of Chemical Engineering, University of Chemistry and Technology, Technicka 5, 166 28 Prague, Czech Republic a r t i c l e i n f o a b s t r a c t Article history: Recent advances in miniaturized cell culture systems have facilitated the screening of media additives on Received 5 October 2015 productivity and protein quality attributes of mammalian cell cultures. However, intracellular compo- Received in revised form 16 April 2016 nents are not routinely measured due to the limited throughput of available analytical techniques. In this Accepted 20 April 2016 work, time profiling of intracellular nucleotides and nucleotide sugars of CHO-S cell fed-batch processes Available online 27 April 2016 in a micro-scale bioreactor system was carried out using a recently developed high-throughput method based on matrix-assisted laser desorption/ionization (MALDI) time-of-flight mass spectrometry (TOF- Keywords: MS).
    [Show full text]
  • Xanthine/Hypoxanthine Assay Kit
    Product Manual Xanthine/Hypoxanthine Assay Kit Catalog Number MET-5150 100 assays FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Xanthine and hypoxanthine are naturally occurring purine derivatives. Xanthine is created from guanine by guanine deaminase, from hypoxanthine by xanthine oxidoreductase, and from xanthosine by purine nucleoside phosphorylase. Xanthine is used as a building block for human and animal drug medications, and is an ingredient in pesticides. In vitro, xanthine and related derivatives act as competitive nonselective phosphodiesterase inhibitors, raising intracellular cAMP, activating Protein Kinase A (PKA), inhibiting tumor necrosis factor alpha (TNF-α) as well as and leukotriene synthesis. Furthermore, xanthines can reduce levels of inflammation and act as nonselective adenosine receptor antagonists. Hypoxanthine is sometimes found in nucleic acids such as in the anticodon of tRNA in the form of its nucleoside inosine. Hypoxanthine is a necessary part of certain cell, bacteria, and parasitic cultures as a substrate and source of nitrogen. For example, hypoxanthine is often a necessary component in malaria parasite cultures, since Plasmodium falciparum needs hypoxanthine to make nucleic acids as well as to support energy metabolism. Recently NASA studies with meteorites found on Earth supported the idea that hypoxanthine and related organic molecules can be formed extraterrestrially. Hypoxanthine can form as a spontaneous deamination product of adenine. Because of its similar structure to guanine, the resulting hypoxanthine base can lead to an error in DNA transcription/replication, as it base pairs with cytosine. Hypoxanthine is typically removed from DNA by base excision repair and is initiated by N- methylpurine glycosylase (MPG).
    [Show full text]
  • Polymeric Derivative of Cytidine Metabolic Antagonist Polymer-Derivat Von Cytidin Metabolit Antagonist Derive Polymere D’Un Antagoniste Metabolique De La Cytidine
    (19) & (11) EP 1 881 020 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C08G 65/08 (2006.01) A61K 38/00 (2006.01) 11.08.2010 Bulletin 2010/32 C08G 65/333 (2006.01) C08G 69/48 (2006.01) (21) Application number: 06745754.9 (86) International application number: PCT/JP2006/308826 (22) Date of filing: 27.04.2006 (87) International publication number: WO 2006/120914 (16.11.2006 Gazette 2006/46) (54) POLYMERIC DERIVATIVE OF CYTIDINE METABOLIC ANTAGONIST POLYMER-DERIVAT VON CYTIDIN METABOLIT ANTAGONIST DERIVE POLYMERE D’UN ANTAGONISTE METABOLIQUE DE LA CYTIDINE (84) Designated Contracting States: • MASHIBA, Hiroko, AT BE BG CH CY CZ DE DK EE ES FI FR GB GR NIPPON KAYAKU KABUSHIKI KAISHA HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI Tokyo 1150042 (JP) SK TR • YAMAMOTO, Keiichirou, Designated Extension States: c/o NIPPON KAYAKU K.K. AL BA HR MK YU Tokyo 1150042 (JP) • TAKASHIO, Kazutoshi, (30) Priority: 11.05.2005 JP 2005138249 NIPPON KAYAKU K.K. Tokyo 1150042 (JP) (43) Date of publication of application: 23.01.2008 Bulletin 2008/04 (74) Representative: Wablat, Wolfgang Patentanwalt (73) Proprietor: NIPPON KAYAKU KABUSHIKI KAISHA Dr. Dr. W. Wablat Tokyo 102-8172 (JP) Potsdamer Chaussee 48 14129 Berlin (DE) (72) Inventors: • MASUDA, Akira, (56) References cited: c/o NIPPON KAYAKU KABUSHIKI KAISHA EP-A- 0 097 307 EP-A- 0 685 504 Tokyo 1150042 (JP) WO-A-01/21135 WO-A-02/065988 • ONDA, Takeshi, JP-A- 6 206 832 JP-A- 02 300 133 c/o NIPPON KAYAKU KABUSHIKI KAISHA JP-A- 06 206 832 JP-A- 08 048 766 Tokyo 1150042 (JP) JP-A- 2003 524 028 JP-A- 2004 532 289 Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.
    [Show full text]
  • Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells'
    [CANCER RESEARCH 35, 1427-1432,June 1975] Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells' William M. Hryniuk2 Larry W. Brox,3J. Frank Henderson, and Taiki Tamaoki DepartmentofMedicine, University ofManitoba,and TheManitoba Institute ofCellBiology, Winnipeg,Manitoba [W. M. H.J and CancerResearch Unit (McEachern Laboratory), and DepartmentofBiochemistry, University ofAlberta, Edmonton,Alberta T6G 2E1 [L. W. B.,J. F. H., T. T.J,Canada SUMMARY recently been shown that the cytotoxicity of methotrexate against cultured mouse lymphoma L5178Y cells is in part Addition of 1 @Mmethotrexate to cultures of L5178Y attributable to a “purineless―state(6, 7). Thus, hypoxan cells results in an initial inhibition ofthymidine, uridine, and thine partially prevented the methotrexate-induced inhibi leucine incorporation into acid-insoluble material followed, tion of thymidine, uridine, and leucine incorporation into after about 10 hr. by a partial recovery in the extent of macromolecules and also delayed the loss ofcell viability, as incorporation of these precursors. Acid-soluble adenosine measured by cloning experiments. These studies also triphosphate and guanosine triphosphate concentrations are showed that, during incubation of L5178Y cells with greatly reduced initially, but guanosine triphosphate con methotrexate in the absence of hypoxanthine, incorporation centrations appear to recover partially by 10 hr. Acid of thymidine into DNA was first inhibited but later partially soluble uridine triphosphate and cytidine
    [Show full text]